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Esenbeckia leiocarpa, a wide spread native Brazilian tree, was reported recently to possess anti-inflammatory effects
in vivo, but the mechanisms involved are still not fully understood and its role in neutrophils is poorly documented.
The aim of this study was to compare the effects of a crude hydroalcoholic extract (CHE) and an alkaloid-enriched
(Alk) fraction obtained from Esenbeckia leiocarpa bark on human neutrophils by investigating the effect of each
fraction alone or in a mixture with classical neutrophil agonists. CHE inhibited intracellular reactive oxygen species
(ROS) production but increased the extracellular superoxide (O2
- ) production, while Alk increased the former and
also slightly increased O2
- production. We found that CHE and Alk also induced phagocytosis accompanied by Syk
activation, adhesion and degranulation. However, neither CHE nor Alk potentiated the effect of classical neutrophil
agonists, namely the cytokines GM-CSF for phagocytosis and TNF-α for adhesion or N-formyl-methionyl-leucyl-
phenylalanine (fMLP) for degranulation. In addition, based on catalase treatment, CHE and Alk induced neutrophil
apoptosis by a hydrogen peroxide (H2O2)-dependent mechanism. Since the elimination of apoptotic neutrophils by
professional phagocytes is important for the resolution of inflammation, the ability of CHE and Alk to induce
neutrophil apoptosis has to be considered as one possible mechanism associated with the anti-inflammatory
activity of these fractions previously reported in vivo.
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Esenbeckia genus (Rutaceae) comprises a variety of species
which have been popularly used to treat malaria in the
Brazilian Amazon region [1,2]. Despite its ethnopharma-
cological approach, other biologic effects have been attrib-
uted to Esenbeckia species, including anticholinesterasic
[3], antimicrobial [4], and antiparasitic [5] properties.
Esenbeckia leiocarpa is a wide spread native Brazilian tree
popularly known as guarantã, goiabeira, or guarataia [3].
Recent studies carried out in our laboratory have shown
that this herb exerts a potent anti-inflammatory effect,* Correspondence: denis.girard@iaf.inrs.ca
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reproduction in any medium, provided the origincluding a decrease in leukocyte migration, exudate
levels, and pro-inflammatory mediators in different in vivo
models [6,7]. Several studies have singled out alkaloids as
being the most abundant class of chemical compounds
present in Esenbeckia leiocarpa [6-9]. Notwithstanding,
these compounds are known for their anti-inflammatory
activity. For instance, phenanthroindolizidine and septi-
cine alkaloid have demonstrated in vitro anti-inflammatory
properties, since they supressed nitric oxide production in
RAW 264.7 cells stimulated with LPS and interferon-γ
(IFN-γ) [10]. Other alkaloids, such as dehydroevodiamine,
evodiamine, and rutaecarpine were effective in reducing
both phorbol 12-myristate 13-acetate (PMA)- and N-for-
myl-methionyl-leucyl-phenylalanine (fMLP)-induced react-
ive oxygen species (ROS) production in neutrophils [11]. In
addition, recent studies have shown that the alkaloidtd. This is an Open Access article distributed under the terms of the Creative
mmons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
inal work is properly cited.
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fibroblast-like synoviocytes [12].
Polymorphonuclear neutrophils (PMNs) have an es-
sential role in the inflammatory response, since they are
the first line of host defense against foreign microorgan-
isms [13]. Notwithstanding, they have been implicated in
the pathogenesis of several inflammatory diseases, in-
cluding rheumatoid arthritis [14], type 2 diabetes [15],
and chronic obstructive pulmonary disease [16]. These
cells are activated and recruited to inflammation sites,
where they exert phagocytic activity against invading
pathogens and release different pro-inflammatory cyto-
kines and chemokines, such as tumour necrosis factor-
alpha (TNF-α) and interleukin-8 (IL-8) [17], as well as a
variety of antimicrobial agents, including cationic pep-
tides, proteases, lactoferrin, myeloperoxidase (MPO),
and reactive oxygen species (ROS) by the exocytosis of
cytoplasmic granules [13]. The aim of the present study
was to compare the effects exerted by the crude hydroal-
coholic extract and by an alkaloid-enriched fraction
obtained from Esenbeckia leiocarpa bark, upon different
neutrophil functions. Our results are the first to show
that alkaloids represent an important fraction containing
molecules responsible for the effect of Esenbeckia leio-
carpa on phagocytosis, adhesion, and degranulation of
human neutrophils, but not on ROS production.
Methods
Reagents
Dimethyl sulfoxide (DMSO), phorbol 12-myrostate 13-
acetate (PMA), tumour necrosis factor-alpha (TNF-α), N-
formyl-methionyl-leucyl-phenylalanine (fMLP), and lipo-
polysaccharide (LPS) were purchased from Sigma-Aldrich
(St. Louis, MO, USA). Granulocyte macrophage colony-
stimulating factor (GM-CSF) was purchased from Pepro
Tech Inc. (Rocky Hill, NJ, USA). The monoclonal anti-
bodies against CD35 (clone E11) and CD63 (clone H5C6)
were purchased from BD PharMingen (San Diego, CA,
USA). The anti-CD66b mAb (clone 80H3) was obtained
from AbDSerotec (Raleigh, NC, USA). The Syk inhibitor
II (catalog no.57472) was purchased from EMD Bios-
ciences. Specific rabbit-anti-human phosphorylated Syk
antibody was purchased from Cell Signaling Technology
(Danvers, MA, USA). Specific mouse Ab anti-human Syk
was purchased from Santa Cruz Biotechnology (Santa
Cruz, CA, USA).
Plant materials, preparation of crude hydroalcoholic
extract and alkaloid fraction
Various samples of bark from Esenbeckia leiocarpa were
collected in Arenápolis, a town located in the state of
Mato Grosso, Brazil. They were collected in August 2007
and were identified by Dr. Celice Alexandre, of the Uni-
versity of the State of Mato Grosso, Tangará da Serra, MT,Brazil, where a voucher specimen (38639) was deposited.
Dried Esenbeckia leiocarpa bark (9 kg) was macerated and
extracted with 90% EtOH (24 h×3) resulting in a crude
hydroalcoholic extract (CHE) (290 g). Some of the CHE
(20 g) was partitioned between EtOAc and 5% HCl solu-
tion. The pH of the acidic water-soluble material was
adjusted to pH 9–10 with 10% ammonia solution and was
then extracted with EtOAc to yield an alkaloid (Alk) frac-
tion (5g) [6,7]. Based on preliminary results, CHE and Alk
were used at concentrations of 500 and 100 μg/mL, re-
spectively; at these concentrations, cell necrosis never
exceeded 5%, as assessed by trypan blue exclusion assay,
and close to 80% of cells were in apoptosis (data not
shown).
Neutrophil isolation
Neutrophils were isolated from venous blood of healthy
volunteers by dextran sedimentation, followed by centrifu-
gation over Ficoll-Hypaque (Amersham Pharmacia Bio-
tech Inc., Baie d’Urfé, Québec, Canada), as described
previously [18]. Blood donations were obtained from
informed and consenting individuals according to institu-
tionally approved procedures. Cell viability was monitored
by trypan blue exclusion and found to be consistently
>98%. Cell purity (>98%) was verified by cytology from
cytocentrifuged preparations coloured by Hema-3 staining
kit (Biochemical Sciences Inc., Swedesboro, NJ, USA). Cell
viability was evaluated systematically before and after each
treatment. Neutrophils were then resuspended (10×106
cells/mL in RPMI-HEPES medium (25 mM), supplemen-
ted with penicillin (100 U/mL)/streptomycin (100 μg/mL))
for all experiments.
Measurement of intracellular ROS production
To determine the effects of CHE and Alk on intracellular levels
of ROS, cells (1 × 106 cells/mL) were incubated for 5, 15, or 30
min with either CHE (500 μg/mL) or Alk (100 μg/mL) in the
presence or absence of phorbol 12-myristate 13-acetate (PMA).
Intracellular levels of ROS were detected using the probe 2′,7′-
dichlorofluorescein diacetate (H2DCFDA; Molecular Probes,
Eugene, OR, USA), as per the manufacturer’s recommendation.
After stimulation, cells were washed with PBS and stained with
non-fluorescent cell-permeable H2DCFDA (5 μg/mL) for 15
min at 37°C. The H2-dichlorofluorescein oxidizes rapidly to the
highly fluorescent dichlorofluorescein by ROS. As a positive
control, the fluorescence intensity of cells pre-treated with
H2DCFDA was measured in the presence of PMA (10
−7 M).
Phagocytosis of sheep erythrocytes
Sheep red blood cells (SRBCs) were opsonized with a
final 1/200 dilution of rabbit IgG anti-SRBC antibody
(Sigma-Aldrich) by incubation for 45 min at 37°C, as
previously described [19,20]. PMNs (4 × 106 cells/mL in
RPMI 1640) were pre-treated 30 min with buffer (1%
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as with CHE (500 μg/mL) or Alk (100 μg/mL), in the
presence or absence of GM-CSF (65 ng/mL). Cells were
also incubated in the presence or absence of two differ-
ent Syk inhibitors, piceatannol (30 μM) or Syk inhibitor
II (30 μM). PMNs were then incubated with 20 × 106
opsonized SRBCs for 45 min as described above. The
samples were centrifuged at 200 × g at 4°C for 10 min.
Supernatants were discarded, and non-ingested SRBCs
were eliminated by performing osmotic shock on the
pellets, by treating them with 300 μL H2O for 15 s fol-
lowed immediately by the addition of 4.5 mL ice-cold
PBS (PBS; 1×). The samples were washed twice with ice-
cold PBS, and the pellets were suspended to a final con-
centration of 4 × 106 cells/mL. Duplicate cytocentrifuged
preparations were prepared in aliquots of ~200 μL,
stained with the Hema-3 staining kit (Biochemical
Sciences Inc., Swedesboro, NJ, USA), and observed by
cytology, essentially as previously documented [19,21].
Phagocytosis was measured as percentage of neutrophils
ingesting at least one opsonized SRBC.
Neutrophil adhesion assay
The adhesion assay was performed essentially as previously
documented [22]. The human epithelial lung cell line A549
(ATCC) was grown in RPMI 1640 supplemented with 10%
FCS and antibiotics. Cell viability was systematically evaluated
before and after each treatment, and mortality never
exceeded 5%. A549 cells were grown on glass coverslips;
when at confluence, they were washed twice with PBS. PMNs
were pre-treated for 30 min with buffer (DMSO 1%) with or
without either CHE (500 μg/mL) or Alk (100 μg/mL) in the
presence or absence of tumour necrosis factor-alpha (TNF-α)
(10 ng/mL), and were labelled for 30 min with 5 μM calcein-
AM (Molecular Probes, Eugene, OR, USA), according to the
manufacturer’s recommendation. After incubation, 500 μL of
neutrophil suspension (10 × 106 cells/mL) was added to each
well of a 12-well plate containing confluent A549 cells on a
coverslip for 30 min. After the incubation, coverslips were ex-
tensively washed and mounted on a glass slide. The number
of adherent PMNs was calculated by counting the number of
fluorescent cells from five randomly selected high-power
fields (400x) observed with a photomicroscope Leica
equipped with an ebq 100 dc epifluorescent condenser.
Degranulation of human neutrophils
Cell surface expression of CD35, CD63, and CD66b was
monitored for assessing degranulation of secretory, azuro-
philic, and specific granules, respectively, by flow cytome-
try, as previously described [23,24]. Briefly, non-specific
binding of the antibodies was prevented by incubating the
cells with PBS+ 20% decomplemented autologous serum
for 30 min on ice. After several washes with PBS, primary
antibodies or an IgG1 isotype control antibody were addedat a concentration of 1 μg/mL in PBS for 30 min on ice.
Cells were washed three times in PBS and incubated with
1 μg/mL FITC-conjugated goat anti-mouse IgG antibody
for 30 min on ice. After three washes, cells were resus-
pended in PBS, and analysis was performed with a FACS-
can (BD Biosciences, San Jose, CA, USA).
Zymography assay
Neutrophils (1 × 106 cells/mL in RPMI 1640 per condi-
tion) were pre-treated 30 min with buffer (1% DMSO),
with or without CHE (500 μg/mL) or Alk (100 μg/mL),
in the presence or absence of LPS (1 μg/mL), and then
centrifuged at 13,000 rpm for 10 min at 4°C, and the
pellets were discarded. The supernatants (5 μL corre-
sponding to 50,000 cells) were mixed with a non-
reducing buffer (40% glycerol, Tris–HCl 1 M, pH 6.8,
SDS 8%) and separated on 7.5% acrylamide gels contain-
ing 0.2% gelatin. Gels were washed twice for 30 min with
2.5% Triton X-100 and incubated overnight in digestion
buffer (Tris–HCl 50 mM, pH 7.4, NaCl 150 mM, CaCl2
5 mM). Gels were stained with Coomassie blue 0.1% and
then destained.
Assessment of neutrophils apoptosis by cytology
Assessment of neutrophil apoptosis was performed essen-
tially as previously described [25]. Briefly, freshly isolated
human neutrophils (10 × 106 cells/mL in RPMI 1640 sup-
plemented with 10% autologous serum) were incubated
for 24h in the presence (+) or absence (−) of CHE, Alk,
with or without catalase. Cytocentrifuged preparations of
neutrophils were performed with a Cyto-tek centrifuge
(Miles Scientific, Elkart, IN, USA), as previously described
and then were stained with the Hema-3 staining kit, as
per the manufacturer’s protocol. Cells were examined by
light microscopy at a final magnification of 400X and
apoptotic neutrophils were defined as cells containing one
or more characteristically dark-stained pyknotic nuclei.
Results were expressed as percentage of cells in apoptosis.
Western blot analysis
Neutrophils (10 × 106 cells/mL in RPMI-HEPES (25 mM),
penicillin (100 U/mL)/streptomycin (100 μg/mL)) were sti-
mulated with GM-CSF (65 ng/mL), CHE (500 μg/mL, Alk
(100 μg/mL), or buffer (DMSO 1%) for 30 min at 37°C. At
the end of the incubation period, the cells were lysed in 4x
Laemmli’s sample buffer (0.25 M Tris–HCl, pH 6.8, 8%
SDS, 40% glycerol, and 20% 2β-ME), and aliquots corre-
sponding to 1 × 106 cells were loaded onto 10% SDS-PAGE
and transferred to nitrocellulose membranes (Amersham
Pharmacia Bio-tech Inc., Baie d’Urfé, Que, Canada). Non-
specific sites were blocked with 3% bovine serum albumin
(BSA) in TBS-Tween (25 mMTris-HCl, pH 7.8, 190
mMNaCl, 0.15% Tween-20), and blots were incubated with


































Figure 1 Effect of CHE and Alk on intracellular ROS production
in human neutrophils. Freshly isolated human PMNs (1 x 106 cells/mL)
were incubated with diluent (1% DMSO in HBSS, Ctrl), the positive control,
PMA, CHE (500 μg/mL), Alk (100 μg/mL), PMA+CHE or PMA+Alk for 5,
15 or 30 min and intracellular ROS production was assessed by flow
cytometry as described in Materials. Results are means±SEM (n=4). *,
p< 0.05 vs Ctrl; #, p< 0.05 vs PMA by student-t test.
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MA, USA) and HRP-goat anti-rabbit (1:15,000) were used.
Membranes were stripped for 30 min at 55°C with stripping
buffer (100 mM 2-ME, 2% SDS, 62.5 mM Tris, pH 6.7),
washed, and reprobed with an specific mouse Ab anti-
human Syk (1:1000; Santa Cruz, CA, USA) followed by a
HRP-conjugated goat anti-mouse IgG+ IgM (1:20,000; Jack-
son ImmunoResearch Laboratories, Inc.). Syk protein ex-




- production was performed by colorimetric assay (re-
duction of cytochrome c), as previously published25.
Briefly, neutrophils (1 × 106 cells/mL in Hank’s balanced
salt solution (HBSS) supplemented with 1.6 M CaCl2)
were incubated with 130 μ cytochrome c (Sigma-
Aldrich) for 5 min at 37°C in the presence (+) or ab-
sence (−) of PMA, CHE or Alk. The absorbance of cyto-
chrome c was monitored at 550 nm and the number of
O2
.- anions produced was calculated as previously pub-
lished [25]using an extinction coefficient of 21.1.
Statistical analysis
Experimental data were expressed as mean ± SEM. Sig-
nificant differences between groups were determined by
Student’s t test, when necessary, or two-way-analysis of
variance (two-way-ANOVA), and then performed using
GraphPad Prism, Version 5.01. Differences were consid-
ered statistically significant as follows: *, P< 0.05 versus
Ctrl or appropriated diluent.
Results and discussion
CHE is an inhibitor and Alk an inducer of ROS production
in human neutrophils
As illustrated in Figure 1, CHE rapidly and significantly
decreased the basal level of ROS production observed
after 5 min of treatment. This decrease persisted for up
to 30 min, as assessed by flow cytometry with the
H2DCFDA fluorescent probe. Unlike CHE, Alk did not
significantly decrease basal ROS production but, rather,
induced it, although not significantly, after 30 min of in-
cubation. ROS production was also determined in PMA-
induced PMNs and both CHE and Alk caused significant
decreases in ROS production.
Modulatory activity of CHE and Alk on the ability of PMNs
to exert phagocytosis, adhesion and degranulation
Given that CHE and Alk can modulate a rapid response
such as ROS production in human PMNs, we then
determined whether or not one or both fraction(s) could
modulate phagocytosis, adhesion and degranulation,
three major functions of PMNs important for host
defense that occurs relatively rapidly. Therefore, weinvestigated the potential modulatory activity of CHE
and Alk on these responses. As illustrated in Figure 2A,
CHE and Alk significantly enhanced Fc-mediated phago-
cytosis of opsonized red blood cells (61.7 ± 3.2% and
73.0 ± 4.6%, respectively (n = 4)) when compared to un-
treated cells (43.0 ± 5.6%), but did not potentiate the ef-
fect of the cytokine GM-CSF. In addition, this figure
shows that the ability of either CHE or Alk to enhance
phagocytosis was reversed by a Syk-selective inhibitor,
indicating that both fractions enhanced phagocytosis by
a Syk-dependent mechanism. To further elucidate this,
we then demonstrated that Syk was activated in re-
sponse to CHE or Alk, as evidenced by its increased
level of phosphorylation (Figure 2B). CHE markedly
increased the adhesion of PMNs on human epithelial
A549 cells (ratio of 5.8 ± 0.8, n = 3); (Figure 3) this
increased adhesion was even greater than that of the po-
tent cytokine TNF-α (3.5 ± 0.9) used as a positive control
in this assay [22]. However, when PMNs were treated
simultaneously with CHE and TNF-α, the resulting ratio
was 4.8 ±0.3, which indicated an effect intermediate be-
tween that produced by either CHE or TNF-α only. Alk
also increased the adhesion of PMNs but to a lesser ex-
tent than CHE (2.4 ±0.1), but when mixed with TNF-α,
the result was similar to that of PMNs treated with
TNF-α only (3.3 ± 1.0). We then evaluated the ability of
CHE and Alk to modulate degranulation in neutrophils
as assessed by flow cytometry, by monitoring cell surface
expression of three important molecules known to be
present in the different types of granule: CD63 (azuro-
philic granules), CD66b (specific and gelatinase granules)
and CD35 (secretory granules) [24,26]. As illustrated in
Figure 4A, CHE and Alk induced, with the same potency,



























Figure 3 CHE and Alk enhance neutrophil adhesion onto cell
substratum. PMNs were incubated with or without CHE, Alk, TNF-α,
CHE + TNF-α or Alk + TNF-α for 30 min, labelled with calcein-AM,
incubated on confluent A549 cells for 30 min and adhesion was
measured as described in Methods. Results are means ± SEM (n = 4)
























































Figure 2 CHE and Alk enhance Fc-mediated phagocytosis by a
Syk-dependent mechanism. PMNs were isolated an incubated in
the presence (+) or absence (−) of GM-CSF, CHE, Alk or Syk II
inhibitor (SykII). Phagocytosis of opsonized SRBCs (A) or Syk
activation (B) were determined as described in Methods. A, results
are means ± SEM (n = 4). *, p< 0.05 vs Ctrl (GM-CSF, CHE, Alk or SykII)
and #, p< 0.05 vs GM-CSF for the indicated columns. B, upper panel
is the phosphorylated form of Syk, whereas the bottom panel
illustrated the non-phosphorylated form of Syk, following stripping
indicating equal protein loading. Results are from one representative
experiment out of three.
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to a lesser extent than fMLP, used as positive control.
The cell surface expression of CD35 was not significantly
modulated when cells were treated with CHE+ fMLP
and Alk + fMLP, when compared with fMLP only. CHE
and Alk increased cell surface expression of CD66b but,
unlike for CD35, when CHE or Alk was mixed with
fMLP, the expression of CD66b was slightly decreased
when compared to that produced by fMLP only
(Figure 4B). Cells surface expression of CD63 remained
stable in response to fMLP when compared to control
cells, but was markedly, and significantly, increased by
CHE and Alk (Figure 4C). In order to support CHE- or
Alk-induced degranulation based on cell surface expres-
sion of a given marker, we then used the supernatants
and performed zymography experiments. As illustrated
in Figure 4D, CHE and Alk increased the activity of the
matrix metalloproteinase-9 (MMP-9), also known as 92
kDa gelatinase (gelatinase B), and MMP-2 or 72 kDa
gelatinase (gelatinase A), as evidenced by an increased
expression of the digested regions (bands) in the gel. Of
note, gelatinase activity was more pronounced in re-
sponse to Alk when compared to CHE. Also, Alk poten-
tiated the activity of LPS, whereas CHE did not (or only
slightly) promote such activity.Inhibition of H2O2 reverses the ability of CHE and Alk to
accelerate apoptosis
Neutrophils are known to undergo spontaneously in
apoptosis (SA) [27] and many agents can accelerate or
delay this biological process [25,28,29]. As illustrated in
Figure 5 both CHE and Alk fractions accelerated SA. As
expected, addition of catalase, an enzyme that degrades
hydrogen peroxide (H2O2), significantly delayed SA [25]
and, also prevented the ability of CHE and Alk to accel-
erate SA. This suggested that CHE and Alk can also
modulate a PMN function requiring several hours of in-
cubation in vitro (24h).CHE and Alk increase extracellular O2
- production in PMNs
Because treatment with catalase inhibited the capacity of
CHE and Alk to induce apoptosis, and since catalase
used in the experiments is not cell permeable and
degraded therefore H2O2 present in the extracellular
medium, we then decided to verify whether extracellular
ROS production was also increased in response to CHE
and Alk. We measured the classic response of O2
- pro-
duction, since O2
- anions are rapidly transformed into
H2O2 via the action of the enzyme superoxide dismutase
(SOD). As illustrated in Figure 6, after only 5 min of
treatment, CHE significantly increased the rapid produc-
tion of O2
- , whereas Alk did not, although a slight ten-
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Figure 4 CHE and Alk induce degranulation in human neutrophils. PMNs were incubated in the presence (+) or absence of fMLP, CHE or Alk
and the release of subset types of granules was evaluated by flow cytometry by monitoring cell surface expression of CD35 (A), CD66b (B) or
CD63 (C), as described in Methods. Results are means ± SEM (n = 4). In panel D, supernatants from PMNs incubated with buffer (Ctrl), LPS, CHE,
CHE+ LPS, Alk, or Alk + LPS were collected and tested by zymography in order to determine whether an enzymatic activity is present, as
described in Methods. Results are from one representative experiment out of four.
Liz et al. Journal of Inflammation 2012, 9:19 Page 6 of 9




The discovery that Esenbeckia leiocarpa possesses some
anti-inflammatory properties in vivo is recent [6,7]. The
present work is the first study to investigate, in parallel,
the role of both the crude hydroalcoholic extract (CHE)
and an alkaloid fraction (Alk), prepared from Esenbeckia
leiocarpa bark in human PMNs, key players in inflam-
mation. The various PMN functions were tested, not
only in CHE- or in Alk-stimulated cells, but also, in cells
treated with a combination of CHE or Alk and classical
PMN agonists, namely, PMA for ROS production, GM-
CSF for phagocytosis, TNF-α for adhesion, and fMLP for
degranulation. This strategy allowed us to study not onlythe direct effect of CHE or Alk on PMNs, but also when
mixed with classical neutrophil agonists, a situation that
is likely to occur in vivo where PMNs could be activated
by several agents during inflammation [30]. From our
results, it is clear that either CHE or Alk showed agonis-
tic activities for human PMNs. This is consistent with a
previous study indicating that E. Leiocarpa exerted an
important anti-inflammatory effect in vivo in neutro-
phils, since a decrease of myeloperoxidase was noted [6],
an enzyme considered as an important marker of PMN
activation [31]. In general, for all tested functions, PMNs
responded to both CHE and Alk in a similar fashion, ex-
cept for ROS production; CHE inhibited intracellular
ROS production but increased the extracellular O2
- pro-
duction, whereas Alk (moderately) increased the former
and also increased O2
































Figure 5 CHE and Alk induce apoptosis in human PMNs by a
H2O2-dependent mechanism. PMNs were isolated and incubated
(10 × 106 cells/mL) with buffer, CHE (500 μg/mL) or Alk (100 μg/mL)
in the presence (+) or absence (−) of catalase (CAT) for 24 h.
Apoptosis was evaluated by cytology as described in Methods.
Results are means ± SEM (n≥ 3). *, p< 0.05 vs Ctrl (CHE, Alk and
CAT), #, p< 0.05 vs CHE or Alk (as indicated) by Student’s t-test.
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enriched fraction also demonstrated similar effects in vivo;
they were found to inhibit leukocyte migration, exudate
concentrations and proinflammatory mediators in carra-
geenan-induced inflammation in the murine air pouch
model [6]. Therefore, Alk possesses some effects different
than CHE in vitro and in vivo. It is difficult to explain with
certainty why CHE decreased intracellular ROS produc-
tion but increased extracellular O2












































Figure 6 Effect of CHE and Alk on superoxide production. PMNs
were incubated in the presence (+) or absence (−) of PMA, CHE or
Alk and O2
.- production was determined after 5 min as described in
Methods. Results are means ± SEM (n = 3). *, p< 0.05 vs Ctrl (no CHE,
Alk or PMA); #, p< 0.05 vs PMA, by Student’s t-test.(slightly to moderately) increased both of these responses.
One of the most probable reasons, although purely specu-
lative at the moment, is the presence of other chemical
compounds in the CHE, apart from alkaloids that are
equally present in the Alk. Of interest, CHE and Alk
increased the PMN apoptotic rate to almost the same level
after 24h and this response was reversed by catalase. This
effect suggests that even if CHE and Alk do not exert a
similar effect upon general ROS production (intra and/or
extracellular), similar levels of H2O2 are eventually present
in the external medium of CHE- or Alk-stimulated PMNs.
Interestingly, the role of H2O2 has been recently deter-
mined during neutrophilic inflammation in vivo during
antigen-induced arthritis[32]. In this study, neutrophil re-
cruitment was delayed in gp91phox KO mice (that do not
generate ROS, at least via NADPH activation) or after ad-
ministration of catalase but was resolved after administra-
tion of H2O2 or superoxide dismutase [32]. Given the
general involvement of ROS during PMN apoptosis, espe-
cially the role of extracellular H2O2 (since addition of cata-
lase almost completely reversed spontaneous or agent-
induced apoptosis [25]), the ability of CHE and Alk to
produce extracellular O2
- , rapidly transformed into H2O2,
is in accordance with the anti-inflammatory properties
observed in vivo, since both CHE and Alk are proapopto-
tic for PMNs, an important event involved in the reso-
lution of inflammation.
For the other functions tested, the difference observed
between CHE and Alk was in terms of intensity of re-
sponse. The most potent in vitro activity of CHE, when
compared to Alk, is its ability to increase the adhesion of
PMNs onto epithelial A549 cells. Whether CHE increased
cell surface expression of some adhesion molecules, not
induced by Alk, or if it acts by increasing such molecule
expression with greater intensity than Alk in PMNs
remains to be determined. The most potent in vitro activ-
ity of Alk when compared to CHE is its ability to strongly
increase a gelatinase activity present in the supernatants,
as assessed by zymography. Although this could not be
directly related to the degranulation of gelatinase or spe-
cific granules (the cell surface expression of the CD66b
marker is similar in CHE- or Alk-induced PMNs), it is im-
portant to specify that other enzymes also possess gelati-
nolytic activity [33] and this could, at least partially,
explain why Alk and LPS had an increased gelatinolytic
activity when compared to CHE. The ability of CHE and
Alk to enhance Fc-mediated phagocytosis of opsonized
SRBCs was, as other PMN agonists, including cytokines
[19,20], linked to Syk activation.
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